Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Location contact
Amy Kogon, MD, MPH
CONTACT
Amy Kogon, MD, MPH
PRINCIPAL_INVESTIGATOR
Jill LoGuidice
CONTACT
NCT Number: NCT06624358
The goal of this is to test the efficacy of a 12-week physical activity intervention in 64 adolescents with CKD.
Interested in participating?
Request Info13 year–18 year
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Amy Kogon, MD, MPH
CONTACT
Amy Kogon, MD, MPH
PRINCIPAL_INVESTIGATOR
Jill LoGuidice
CONTACT
For youth with chronic kidney disease (CKD), cardiovascular disease (CVD) is a leading cause of morbidity and early mortality. Physical activity is a well-recognized determinant of health and quality of life, but, youth with CKD are less physically active than their healthy peers. Identification of effective strategies to increase physical activity in youth with CKD is paramount to improving outcomes. The investigators will test the efficacy of a 12-week physical activity intervention in 64 adolescents with CKD. Guided by the Multiphase Optimization Strategy (MOST) framework, an optimization trial will identify intervention components that increase average daily moderate to vigorous physical activity by 15 min/day, a clinically meaningful increase. The components will be grounded in established behavioral change theories and be delivered via Way to Health, a web-based platform, to overcome barriers at the point of clinical care where time and resources are limited.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For adolescent participants:
For caregiver participants:
Exclusion criteria
For adolescent participants:
For caregivers participants:
Behavioral interventions to improve physical activity
Time frame: pre 12 week intervention and post 12 week intervention
Change in time spent in moderate to vigorous physical activity measured by Fitbit over the course of 12 weeks
Time frame: at the end of the 12 week intervention
At completion of 12 week intervention, participants will complete an exit survey to collect feedback about the participant's experience. This is not scored.
Time frame: 6 months
measure moderate to vigorous physical activity by Fitbit 3 months after completion of 12 week intervention
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 15 items from PROMIS anxiety domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 14 items from PROMIS anxiety domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 39 items from PROMIS positive affect domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 9 items from PROMIS anger domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 19 items from PROMIS stress domain. Participants rate their experience using a five point scale ranging from never to always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12-week intervention and post 12-week intervention
Change in hand grip strength measured by digital hand dynamometer as a age and sex z-score generated from normative data. Z-score is a statistical measurement that describes a values relationship to the mean of a group of values. Values above the mean have positive standard scores, while those below the mean have negative standard scores.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 25 items from PROMIS fatigue domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 15 items from PROMIS sleep disturbance domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 13 items from PROMIS sleep-related impairment domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Time frame: pre 12 week intervention and post 12 week intervention
Patient self-report of 42 items from PROMIS life satisfaction domain. Participants rate their experience using a five point scale ranging from never to almost always. Answers are converted to a t-score to compare to the general population. A higher PROMIS T-score represents more of the concept being measured.
Contact information is provided by the study sponsor or research team.
Amy Kogon, MD MPH
CONTACT
Jillian LoGuidice, BS
CONTACT
Children's Hospital of Philadelphia
Other
Physical Activity in Adolescents With Chronic Kidney Disease
Acronym: PACKD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05173714
Body Weight, Chronic Disease
Stanford, California, United States
View Trial DetailsNCT06810622
Bronchial Diseases, Bronchiolitis
Denver, Colorado, United States
View Trial DetailsNCT06738394
Chronic Disease, Chronic Kidney Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06051058
Cardiovascular Diseases, Chronic Disease
Boston, Massachusetts, United States
View Trial Details